Home
 /
Papers
 /
Molecular Biology
 /
Molecular surface mimicry enables CRBN to target G3BP2 for degradation
Preprint
Open access
V1
Top 1% · Validated by QED

Molecular surface mimicry enables CRBN to target G3BP2 for degradation

Stefano Annunziato, Chao Quan, Etienne J. Donckele +30 more
May 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.04.30.651496
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Molecular Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By revealing that CRBN mimics a target's endogenous partner to recruit G3BP2 through its LON domain, this work overturns the G-loop paradigm and unlocks a vastly expanded protein repertoire for molecular glue degraders.

QED claims analysis

Summary

The CRBN neosubstrate G3BP2 bypasses the canonical G-loop recognition mechanism and is recruited through a novel molecular surface mimicry mechanism in which CRBN's LON domain mimics the natural G3BP2 binding partner USP10, repurposing a preexisting PPI hotspot on the target protein's NTF2L domain to enable MRT-5702-mediated degradation through an unconventional binding interface that is structurally and mechanistically distinct from all previously characterized CRBN neosubstrates.

See full analysis
Main Claim 1 –

MRT-5702 Induces CRBN-Mediated Recruitment and Degradation of G3BP2

Supporting evidence

  • MRT-5702 Selectively Drives CRBN–G3BP2 Ternary Complex Formation
  • G3BP2 NTF2L Domain Is Necessary and Sufficient for Degradation
  • Purified G3BP2 NTF2L Forms CRBN–MRT-5702 Ternary Complex In Vitro
Main Claim 2 –

CRBN Mimics Endogenous Partner to Bind G3BP2 PPI Hotspot

Supporting evidence

  • Predicted CRBN–G3BP2 Interface Residues Are Required for Ternary Complex
Main Claim 3 –

Cryo-EM Confirms G3BP2 Hotspot Binding to CRBN F150–I152

Supporting evidence

  • Only (S,S) MRT-5702D Stereoisomer Triggers G3BP2 Degradation
  • (S,S) MRT-5702D Best Fits Cryo-EM Ligand Density
  • CRBN LON-Loop Flexibility Enhances Complementarity for G3BP2 Binding
  • G3BP2 Bypasses Canonical CRBN Site via LON Domain Interface

Abstract

Molecular glue degraders (MGDs) are small molecule compounds that repurpose the ubiquitin-proteasome system to induce degradation of challenging therapeutic targets. Clinically effective MGDs bind cereblon (CRBN), a substrate receptor of the Cullin-4/RING E3 ubiquitin ligase (CRL4CRBN), and impose a gain-of-function activity to recruit, ubiquitinate and degrade so-called neosubstrate proteins. Known neosubstrates bind the CRBN/MGD neosurface on the CRBN CULT domain through a structural G-loop recognition motif that mimics contacts of a natural CRBN degron. Here we report the binding mode of G3BP2, a CRBN neosubstrate that bypasses the G-loop requirement by engaging an unconventional binding site on the CRBN LON domain. The MGD-induced ternary complex interface does not resemble known protein-protein interactions (PPI) with CRBN. Instead, CRBN mimics an endogenous binding partner of G3BP2 and repurposes a preexisting PPI hotspot on the target protein. Our findings provide a novel generalizable concept for the rationalization of unconventional neosubstrate binding modes on CRBN, demonstrate unprecedented potential for the reprogrammability of this substrate receptor by MGDs, and offer opportunities for rational expansion of the target repertoire accessible to this modality.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?